ESPR icon

Esperion Therapeutics

139 hedge funds and large institutions have $299M invested in Esperion Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

12.7% less ownership

Funds ownership: 100.53%87.84% (-13%)

19% less call options, than puts

Call options by funds: $9.22M | Put options by funds: $11.4M

50% less capital invested

Capital invested by funds: $598M → $299M (-$299M)

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.22M
Puts
$11.4M
Net Calls
Net Calls Change

Top Buyers

1 +$3.06M
2 +$2.31M
3 +$2.23M
4
CS
Credit Suisse
Switzerland
+$1.92M
5
Millennium Management
Millennium Management
New York
+$1.81M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.41M
27
$1.39M
28
$1.33M
29
$1.25M
30
$1.23M
31
$1.22M
32
$1.14M
33
$1.11M
34
$1.04M
35
$1.03M
36
$929K
37
$874K
38
$850K
39
$847K
40
$821K
41
$816K
42
$765K
43
$734K
44
$667K
45
$631K
46
$602K
47
$597K
48
$588K
49
$585K
50
$581K